shopping cart Your cart is empty
  • Home
  • Pharmaceutical
  • Organ on Chip Market By Product (Lungs on Chip, Heart on Chip, Liver in Chip, Kidney on Chip, Others), By End User (Research Insti...

Organ on Chip Market By Product (Lungs on Chip, Heart on Chip, Liver in Chip, Kidney on Chip, Others), By End User (Research Institutes, Pharmaceutical Manufacturers) - Growth, Future Prospects and Competitive Analysis, 2018 – 2026

Published By: Brisk Insights | Published On: Jan 19, 2022

 

Enhancing the viability of preclinical expectations human drugs reactions is critical to reducing expensive failures in clinical trials. The pharmaceutical industry is confronting phenomenal challenges attributable to increasing expenses and the declining efficiency of drug research and development. Late advances in microfabrication, cell biology and microfluidics has empowered the improvement of micro-engineered models of the useful parts of human body known as the organ on chip. 

 

Organs on chip are micro-engineered biometric systems that imitate the main purpose of living organs. These micro-devices give a more precise model than traditional cell culture for recreating composite cell-matrix and cell-cell collaborations. In this manner, they possibly represent a fascinating tool for chemical and pharmaceutical applications. They additionally permit to contemplate human physiology for a particular organ and in this way empower the improvement of a novel in vitro disease models. Several research activities have been conducted by the different companies and research institutes to bring this advanced technology to the market. Currently, there are limited companies involved in the development of organ on chip, but it is expected that the number of players will increase in the future. 

 

The purpose of this research study titled ‘Organ on Chip Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026’ is to offer stakeholders, manufactures, business representatives and industry sponsors with exhaustive exploration to allow them to take planned initiatives and resolutions allied to the expectations in the global organ on chip market. This report presents and assesses the chief scenarios in the overall organ on chip market and the market size and forecast. 

 

This report classifies the worldwide organ on chip market in terms of products, end users, and geographical distribution. Based on product types, the global organ on chip market is classified into lungs on chip, heart on chip, liver on chip, kidney on chip, and others. The end users considered for the purpose of this study are research institutes and pharmaceutical manufacturers. Market size and forecast for every cited division for the period from 2016 to 2026 are offered in the report alongside particular CAGRs for the forecast period from 2018 to 2026.

 

This report includes regional market divisions accompanied by leading countries, which are presented as follows:

 

  • Europe
    • Germany
    • United Kingdom
    • Rest of Europe
  • North America
    • Canada       
    • United States
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

 

This study covers a thorough depiction of the above-indicated market segments for the duration from 2016 to 2026. 

 

An exhaustive investigation of market situations has been provided in the report to get a proper comprehension of the market and the associated trends. Various tools are utilized in the report to decide the competition between foremost market players. The study additionally contains company profiling of the market players having a prominent hold on the overall organ on chip market market. Some of the foremost players in the global organ on chip market recorded in this study are: Ascendance Biotechnology, CN Bio Innovations, Emulate, Inc          ., HµREL Corporation, Insphero AG, MIMETAS B.V., Nortis Inc., TARA Biosystems, Inc., and TissUse GmbH.

 

For the purpose of this study, the global organ on chip market is studied for the following product types:

 

  • Lungs on Chip
  • Heart on Chip
  • Liver in Chip
  • Kidney on Chip
  • Others

 

Cumulative burden of growing incidences of heart and kidney related disorders will help in driving the organ on chip market. Lungs on chip dominated the market in 2017 and it is anticipated to continue its supremacy in the forecast period 2018-2026. The heart on chip segment has higher potential for growth as it is the fastest growing market. The organ on chip market will experience an impressive growth rate mostly due to surge in aged population, along with growth in the number of patients suffering from lungs and heart diseases, and the growing need for new technologies to be used as novel tools in drug discovery and development. Amplified skills and consciousness has also resulted in growing acceptance of novel and enhanced technologies by physicians for disease diagnosis. Rapid evolution of healthcare sector and advancement in technology are therefore some of the selected drivers for the rise of the global organ on chip market.

 

For the purpose of this study, global organ on chip market is studied for their application in following usage areas:

 

  • Research Institutes
  • Pharmaceutical Manufacturers 

 

Among the considered usage areas, organ on chip technology enjoys the largest application in research institutes followed by pharmaceutical manufacturers. Higher affordability of research institutes for uptake of organ on chip, greater handling skills and new drug discovery are the foremost factors driving the organ on chip market in research institutes. It is further anticipated that the growing preference for early drug testing results and the need of more reliable data will enhance the demand for organ on chip during the forecast period. Therefore it is predictable that the growth of research institutes sector will be greater than the global benchmark during the forecast period.

 

Geographically, the global organ on chip market is composed of Latin America, Middle East & Africa, Europe, Asia Pacific, and North America. 

 

North America holds the major share in global organ on chip market trailed by Europe. Major reasons for the incumbent status of these regions are them being early adopters of new advanced technologies, presence a huge consumer base, and higher organ transplant rate. Furthermore, Asia Pacific is a remunerative market for the companies involved in organ on chip market. Though, widespread commercialization of this technology is not expected to happen in early years, as the market is still in initial stage in developed regions, it would take a couple of years before organizations can assume return on benefit. China and Japan are main market in the region. Need for advanced testing and research technologies and time saving techniques will enhance the market growth in the future. In the course of forecast duration 2018 to 2026, Europe is observed as the fastest growing region followed by Asia Pacific.

 

The geographical classification of the global organ on chip market is as follows:

 

  • Asia Pacific (Japan, China, and Rest of Asia Pacific)
  • North America (Canada & United States)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
  • Europe (Germany, U.K., and Rest of Europe)
  • Latin America (Mexico, Brazil, and Rest of Latin America)

 

Chapter 1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

 

Chapter 2. Executive Summary


2.1. Global Organ on Chip Market Portraiture
2.1.1. Global Organ on Chip Market, by Product, 2017 (US$ Mn)
2.1.2. Global Organ on Chip Market, by End Users, 2017 (US$ Mn)
2.1.3. Global Organ on Chip Market, by Geography, 2017 (US$ Mn)

 

Chapter 3. Organ on Chip: Market Dynamics and Outlook


3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Top Three Countries
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2017

 

Chapter 4. Global Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)


4.1. Overview
4.1.1. Attractive Investment Proposition, by Product, 2017
4.2. Lungs on Chip
4.3. Heart on Chip
4.4. Liver in Chip
4.5. Kidney on Chip
4.6. Others

 

Chapter 5. Global Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)


5.1. Overview
5.1.1. Comparative Analysis, by End Users, 2017 vs. 2026 (Value %)
5.2. Research Institutes
5.3. Pharmaceutical Manufacturers

 

Chapter 6. Global Organ on Chip Market, by Geography, 2016 – 2026 (US$ Mn)


6.1. Overview
6.2. North America Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.2.1. North America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.2.3. North America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.3.1. Europe Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.3.3. Europe Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.5.1. Latin America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.6.1. MEA Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.6.3. MEA Organ on Chip Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

 

Chapter 7. Company Profiles


7.1. Ascendance Biotechnology
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. CN Bio Innovations
7.3. Emulate, Inc.
7.4. HµREL Corporation
7.5. Insphero AG
7.6. MIMETAS B.V.
7.7. Nortis Inc.
7.8. TARA Biosystems, Inc.
7.9. TissUse GmbH Pioneer Surgical Technology

TABLE 1 Global Organ on Chip Market Portraiture
TABLE 2 Global Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 4 North America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 5 North America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 6 North America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East and Africa Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 19 Ascendance Biotechnology: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 CN Bio Innovations: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Emulate, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 HµREL Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Insphero AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 MIMETAS B.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Nortis Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 TARA Biosystems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 TissUse GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

FIG. 1 Organ on Chip: Market Segmentation
FIG. 2 Global Organ on Chip Market, by Product, 2017 (US$ Mn)
FIG. 3 Global Organ on Chip Market, by End Users, 2017 (US$ Mn)
FIG. 4 Global Organ on Chip Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Lungs on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Heart on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Liver in Chip Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Kidney on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Others Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Organ on Chip in Research Institutes Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Organ on Chip in Pharmaceutical Manufacturers Market, 2016 – 2026 (US$ Mn)
FIG. 14 U.S. Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 15 Canada Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 16 U.K. Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 17 Germany Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Europe Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 19 Japan Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 20 China Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Asia Pacific Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 22 Brazil Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 23 Mexico Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of Latin America Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 25 GCC Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of Middle East and Africa Organ on Chip Market, 2016 – 2026 (US$ Mn)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)